QAI Labs Ltd is a Delaware C-corp headquartered in Sugar Land, Texas, with an Asia-Pacific origination footprint. We hire for technical depth and editorial taste. Open roles below; expression-of-interest welcome for Phase 2 roles.
Own significant surface area across NOVA-Dashboard, the platform API, and the Module Library backend. We are looking for someone who has shipped production systems in Python (FastAPI, async, typed) and TypeScript (React, the kind of frontend that does not embarrass us), and who reads SQL fluently. You will work directly with the founders and the platform leads.
Sit between the generator stack (Boltz-2, ESM-3, RFantibody) and the three NOVA-3 program-specific heads. You should be comfortable with PyTorch, with reading recent antibody and protein design literature, and with the engineering reality of running benchmarks that other people will reproduce. Structural biology background or strong ML-for-biology track record required.
Lead origination and partner conversations across Japan, Korea, Greater China, and Southeast Asia. We are looking for someone who has run pharma BD before, can read a term sheet without flinching, and can hold a serious scientific conversation with a partner's CSO. The first conversation usually starts with a P3 walkthrough and an Evidence Bundle review.
Will own regulatory strategy across our internal programs as they move toward IND-readiness, including FDA and EMA interaction planning and CMC documentation strategy. Open at Phase 2; expressions of interest welcome now and will be held on file with priority review when the role activates.
Will run the wet-lab side of the data flywheel — partner-lab coordination, assay QC, sample logistics, and the data-back-into-platform pipeline that feeds NOVA-Evidence. Open at Phase 2; expressions of interest welcome now from candidates with biotech operations experience and a tolerance for spreadsheets.